Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan Province, China.
Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Prev Med. 2021 Jul;148:106551. doi: 10.1016/j.ypmed.2021.106551. Epub 2021 Apr 18.
Debate over the cardio-cerebrovascular risk associated with metabolically healthy obesity (MHO) continues. In this study we investigated the association of MHO with the risk of stroke among 221,114 individuals aged 40 years or older based on data from the China National Stroke Screening and Prevention Project (CNSSPP), a nationally representative cross-sectional study, during 2014 to 2015. Different metabolic health and obesity phenotypes were defined according to the Adult Treatment Panel III (ATP III) criteria, where obesity was defined as a body mass index (BMI) ≥28 kg/m. Logistic regression models were used to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) for stroke risk associated with different metabolically healthy phenotypes. BMI was used to estimate the mediation effect for metabolic abnormalities to stroke. Compared with the metabolically healthy non-obesity (MHNO) group, individuals with MHO (adjusted OR: 1.21, 95% CI: 1.10,1.33), metabolically unhealthy non-obesity (MUNO) (adjusted OR:1.41, 95% CI: 1.36,1.46), or metabolically unhealthy obesity (MUO) (adjusted OR: 1.70, 95% CI: 1.61,1.80) were found to have an increased risk of stroke. The findings were confirmed robustly by various sensitivity analyses and subgroup analyses. Furthermore, obesity and metabolic abnormalities had an additive interaction for stroke risk with an attributable proportion (AP) of 14.0% in females. BMI played a partial mediating role with the proportion of the effect (PE) at 11.1% in the relationship between metabolic abnormalities and stroke. This study strengthens the evidence that management and interventions in the MHO population may contribute to the primary prevention of stroke.
关于代谢健康肥胖(MHO)与心血管疾病风险之间的争论仍在继续。本研究基于中国国家卒中筛查与防治工程(CNSSPP)的数据,该工程是一项全国代表性的横断面研究,在 2014 年至 2015 年期间调查了 221114 名年龄在 40 岁及以上的个体中,MHO 与卒中风险之间的关系。根据成人治疗小组 III(ATP III)标准,定义了不同的代谢健康和肥胖表型,其中肥胖定义为身体质量指数(BMI)≥28kg/m²。使用逻辑回归模型估计与不同代谢健康表型相关的卒中风险的优势比(OR)和 95%置信区间(CI)。使用 BMI 估计代谢异常与卒中的中介效应。与代谢健康非肥胖(MHNO)组相比,MHO 个体(调整后的 OR:1.21,95%CI:1.10,1.33)、代谢不健康非肥胖(MUNO)个体(调整后的 OR:1.41,95%CI:1.36,1.46)或代谢不健康肥胖(MUO)个体(调整后的 OR:1.70,95%CI:1.61,1.80)患卒中的风险增加。各种敏感性分析和亚组分析也证实了这一发现是稳健的。此外,肥胖和代谢异常对女性卒中风险有相加交互作用,归因比例(AP)为 14.0%。BMI 在代谢异常与卒中之间的关系中起部分中介作用,效应比例(PE)为 11.1%。本研究进一步证实了 MHO 人群的管理和干预可能有助于卒中的一级预防。